• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

5

CATEGORIES

  • 6
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

7
8
10
17

PUBLISHED

0
2
4
17

PRODUCT TYPE

10
7

Search "Albany Molecular Research Inc-Deals & Alliances Report" returned 17 results.

PRODUCT TITLE
Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM

Albany Molecular Research, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

August 2014
FROM

Albany Molecular Research, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

August 2014
FROM
Albany Molecular Research Inc-Detailed Product Pipeline Albany Molecular Research Inc-Detailed Product Pipeline - Product Thumbnail Image

Albany Molecular Research Inc-Detailed Product Pipeline

Albany Molecular Research Inc-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and...

March 2011
FROM

Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies

“Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies” provides key data, information and analysis of the major trends and developments...

March 2011
FROM
Albany Molecular Research Inc-Therapeutic Competitors Albany Molecular Research Inc-Therapeutic Competitors - Product Thumbnail Image

Albany Molecular Research Inc-Therapeutic Competitors

Albany Molecular Research Inc-Therapeutic Competitors Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company...

March 2011
FROM
Drug Discovery Technologies - Global Strategic Business Report Drug Discovery Technologies - Global Strategic Business Report - Product Thumbnail Image

Drug Discovery Technologies - Global Strategic Business Report

This report analyzes the worldwide markets for Drug Discovery Technologies in Millions of US$. The specific technology types analyzed are Bioanalytical Instruments, High Throughput Screening (HTS),...

October 2008
FROM
Antibiotics Partnering Terms and Agreements Antibiotics Partnering Terms and Agreements - Product Thumbnail Image

Antibiotics Partnering Terms and Agreements

The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

December 2013
FROM
ADME-Toxicology Testing - Global Strategic Business Report ADME-Toxicology Testing - Global Strategic Business Report - Product Thumbnail Image

ADME-Toxicology Testing - Global Strategic Business Report

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Annual estimates and forecasts are provided for the period 2009 through 2018 Market...

October 2013
FROM
Biochips - Global Strategic Business Report Biochips - Global Strategic Business Report - Product Thumbnail Image

Biochips - Global Strategic Business Report

This report analyzes the worldwide markets for Biochips in US$ Million by the following Product Segments: DNA Chips, Protein Chips, and Lab Chips Annual estimates and forecasts are provided for the...

March 2012
FROM

Outsourcing in Drug Discovery

The number and scope of drug discovery outsourcing agreements has grown rapidly over the past five years, and the pace will accelerate over the next five years. Outsourcing is now an essential part...

May 2003
FROM

Colon Cancers - Pipeline Review, Q1 2011

Colon Cancers - Pipeline Review, Q1 2011 Summary Global Markets Direct’s, 'Colon Cancers - Pipeline Review, Q1 2011', provides an overview of the Colon Cancers therapeutic pipeline. This report provides...

February 2011
FROM
Leukemias - Pipeline Review, H1 2012 Leukemias - Pipeline Review, H1 2012 - Product Thumbnail Image

Leukemias - Pipeline Review, H1 2012

Leukemias – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Leukemias - Pipeline Review, H1 2012', provides an overview of the Leukemias therapeutic pipeline. This report provides information...

January 2012
FROM

Outsourcing in Drug Discovery, 2nd Edition

In the Spring of 2003, Kalorama published its first report on Outsourcing in Drug Discovery. Since then, so much has changed, the use of the term "2nd Edition" hardly seems appropriate. This new study...

January 2006
FROM
Pharmaceutical Product Development, Inc. (PPDI) - Financial and Strategic SWOT Analysis Review Pharmaceutical Product Development, Inc. (PPDI) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Pharmaceutical Product Development, Inc. (PPDI) - Financial and Strategic SWOT Analysis Review

Pharmaceutical Product Development, Inc. (PPDI) - Financial and Strategic SWOT Analysis Review Summary Pharmaceutical Product Development, Inc. (PPD) is a contract research organization that offers...

September 2011
FROM
Evotec Aktiengesellschaft (EVT) - Financial and Strategic SWOT Analysis Review Evotec Aktiengesellschaft (EVT) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Evotec Aktiengesellschaft (EVT) - Financial and Strategic SWOT Analysis Review

Evotec Aktiengesellschaft (EVT) - Financial and Strategic SWOT Analysis Review Summary Evotec Aktiengesellschaft (Evotec) is a biopharmaceutical company engaged in discovering and developing novel...

May 2011
FROM

Early Toxicology: Markets and Approaches

Early toxicology testing is emerging as one of the mostsignificant areas of drug discovery. Toxicity is no longer something that can be left to the development stage, or just a small part of ADMET....

September 2012
FROM
Loading Indicator

Our Clients

Our clients' logos